Rankings
▼
Calendar
SION Q3 2024 Earnings — Sionna Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SION
Sionna Therapeutics, Inc.
$2B
Q3 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$28M
Net Income
-$25M
EPS (Diluted)
$-0.58
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$18M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$197M
Total Liabilities
$346M
Stockholders' Equity
-$149M
Cash & Equivalents
$36M
← FY 2024
All Quarters
Q4 2024 →